KRAS and colorectal cancer: The mutant KRAS peptide vaccine comprises a mixture of six 21-amino-acid-long synthetic peptides encompassing common KRAS hotspot mutations in pancreatic and colorectal cancer—five alterations at the G12 position and one alteration at the G13 position.